Trust versus concerns—how parents reason when they accept HPV vaccination for their young daughter

References

• Mosina L, Martin R, Eckert L. HPV vaccination in Europe: Experience from National Immunization Programmes WHO. 2010. Available from http://www.who.int/immunization_delivery/systems_policy/HPV_vaccination_in_Europe.pdf. accessed 9 January 2012.
   Google Scholar
• The National Board of Health and Welfare [Socialstyrelsen]. Background to a vaccination programme for the human papilloma virus in Sweden 2007; 2008. Available from http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/8868/2008-132-2_20081322.pdf. accessed 14 August 2012.
   Google Scholar
• Limia A, Pachon I. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain. Euro Surveill. 2011. 16:pii:19873. Available from http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19873.
   Google Scholar
• Swedish Association of Local Authorities and Regions [Sveriges Kommuner och Landsting, SKL]. Consentform HPV vaccination Stockholm, Sweden. 2013. Available from http://www.skl.se/vi_arbetar_med/halsaochvard/lakemedel/vacciner/samtyckesblankett. accessed 28 March 2013.
   Google Scholar
• Leval A, Herweijer E, Arnheim-Dahlstrom L, Walum H, Frans E, Sparen P, et al. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis. 2012;206:860–6.
   PubMed Web of Science ®Google Scholar
• Leval A, Herweijer E, Ploner A, Eloranta S, Fridman Simard J, Dillner J, et al. Quadrivalent HPV-vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst. 2013;105:469–74.
   PubMedGoogle Scholar
• Widgren K, Simonsen J, Valentiner-Branth P, Molbak K. Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark. Vaccine. 2011;29:9663–7.
   PubMed Web of Science ®Google Scholar
• Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69:475–80.
   PubMed Web of Science ®Google Scholar
• Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med. 2010;7:e1000270.
   PubMed Web of Science ®Google Scholar
• Trim K, Nagji N, Elit L, Roy K. Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: a systematic review from 2001 to 2011. Obstet Gynecol Int. 2012;2012:921236.
   PubMedGoogle Scholar
• Dempsey AF, Abraham LM, Dalton V, Ruffin M. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol. 2009;19:531–8.
   PubMed Web of Science ®Google Scholar
• Perkins RB, Pierre-Joseph N, Marquez C, Iloka S, Clark JA. Why do low-income minority parents choose human papillomavirus vaccination for their daughters? J Pediatr. 2010;157:617–22.
   PubMed Web of Science ®Google Scholar
• Dahlstrom LA, Tran TN, Lundholm C, Young C, Sundstrom K, Sparen P. Attitudes to HPV vaccination among parents of children aged 12–15 years—a population-based survey in Sweden. Int J Cancer. 2010;126:500–7.
   PubMedGoogle Scholar
• Marlow LA. HPV vaccination among ethnic minorities in the UK: knowledge, acceptability and attitudes. Br J Cancer. 2011;105:486–92.
   Web of Science ®Google Scholar
• Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2011;38:197–204.
   PubMed Web of Science ®Google Scholar
• Marshall H, Ryan P, Roberton D, Baghurst P. A cross-sectional survey to assess community attitudes to introduction of human papillomavirus vaccine. Aust N Z J Public Health. 2007;31:235–42.
   PubMed Web of Science ®Google Scholar
• Burnard P, Gill P, Stewart K, Treasure E, Chadwick B. Analysing and presenting qualitative data. Br Dent J. 2008;204:429–32.
   PubMed Web of Science ®Google Scholar
• Guba E, Lincoln Y. Fourth generation evaluation. Newbury Park, CA: Sage publications; 1989.
   Google Scholar
• Ward KF, Menzies RI, Quinn HE, Campbell-Lloyd S. School-based vaccination in NSW. N S W Public Health Bull. 2010;21:237–42.
   Google Scholar
• Medical Products Agency [Läkemedelsverket]. The Medical Products Agency coordinates research around vaccine safety and narcolepsy. 2012. Available from http://www.lakemedelsverket.se/Alla-nyheter/NYHETER-2012/Lakemedelsverket-samordnar-forskning-kring-vaccinsakerhet-och-narkolepsi-/. cited 18 June 2012.
   Google Scholar
• Swedish Institute for Communicable Disease Control [Smittskyddsinstitutet]. Statistics for HPV vaccinations. 2013. Available from http://www.smittskyddsinstitutet.se/nyhetsarkiv/2013/stor-andel-flickor-vaccinerade-sig-mot-hpv/. cited 8 February 2013.
   Google Scholar
• Abdelmutti N, Hoffman-Goetz L. Risk messages about HPV, cervical cancer, and the HPV vaccine Gardasil: a content analysis of Canadian and U.S. national newspaper articles. Women Health. 2009;49:422–40.
   PubMed Web of Science ®Google Scholar
• Cooper Robbins SC, Bernard D, McCaffery K, Brotherton J, Garland S, Skinner SR. "Is cancer contagious?": Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination. Vaccine. 2010;28:3398–408.
   PubMed Web of Science ®Google Scholar